Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP

Neurology

Volumn 66, Issue 1, 2006, Pages 41-48

  Josephs, K A ^a   Petersen, R C ^a   Knopman, D S ^a   Boeve, B F ^a   Whitwell, J L ^a   Duffy, J R ^a   Parisi, J E ^a   Dickson, D W ^b  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAU PROTEIN; BIOLOGICAL MARKER;

ADULT; AGED; APHASIA; ARTICLE; CLINICAL FEATURE; CORTICOBASAL DEGENERATION; DISEASE ASSOCIATION; FEMALE; FRONTOTEMPORAL DEMENTIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOTONEURON; MOTOR NEURON DISEASE; NERVE DEGENERATION; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; BRAIN; CELL INCLUSION; CLASSIFICATION; DEMENTIA; DIFFERENTIAL DIAGNOSIS; METABOLISM; MIDDLE AGED; NERVE CELL; PATHOLOGY; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; PRIMARY PROGRESSIVE APHASIA; TAUOPATHY;

AGED; APHASIA, PRIMARY PROGRESSIVE; BIOLOGICAL MARKERS; BRAIN; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INCLUSION BODIES; MALE; MIDDLE AGED; MOTOR NEURON DISEASE; NEURONS; PREDICTIVE VALUE OF TESTS; SUPRANUCLEAR PALSY, PROGRESSIVE; TAU PROTEINS; TAUOPATHIES;

EID: 33645729013     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000191307.69661.c3     Document Type: Article

References (47)

1. Kertesz A, Hillis A, Munoz. Frontotemporal degeneration, Pick's disease, Pick complex, and Ravel. Ann Neurol 2003;54:S1-2.
2. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 2001;58:1803-1809.
3. Hauw JJ, Daniel SE, Dickson D, et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 1994;44:2015-2019.
4. Dickson DW, Bergeron C, Chin SS, et al. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol 2002;61:935-946.
5. Dickson DW. Pick's disease: a modern approach. Brain Pathol 1998;8:339-354.
6. Bigio EH, Lipton AM, Yen SH, et al. Frontal lobe dementia with novel tauopathy: sporadic multiple system tauopathy with dementia. J Neuropathol Exp Neurol 2001;60:328-341.
7. Rademakers R, Cruts M, van Broeckhoven C. The role of tau (MAPT) in frontotemporal dementia and related tauopathies. Hum Mutat 2004;24:277-295.
8. Josephs KA, Holton JL, Rossor MN, et al. Frontotemporal lobar degeneration and ubiquitin immunohistochemistry. Neuropathol Appl Neurobiol 2004;30:369-373.
9. Jackson M, Lennox G, Lowe J. Motor neurone disease-inclusion dementia. Neurodegeneration 1996;5:339-350.
10. Mitsuyama Y. Presenile dementia with motor neuron disease in Japan: clinico-pathological review of 26 cases. J Neurol Neurosurg Psychiatry 1984;47:953-959.
11. Knopman DS, Mastri AR, Frey WH 2nd, Sung JH, Rustan T. Dementia lacking distinctive histologic features: a common non-Alzheimer degenerative dementia. Neurology 1990;40:251-256.
12. Josephs KA, Holton JL, Rossor MN, et al. Neurofilament inclusion body disease: a new proteinopathy? Brain 2003;126:2291-2303.
13. Cairns NJ, Grossman M, Arnold SE, et al. Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease. Neurology 2004;63:1376-1384.
14. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546-1554.
15. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. A heterogenous degeneration involving the brain stem, basal ganglia and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964;10:333-359.
16. Rebeiz JJ, Kolodny EH, Richardson EP Jr. Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol 1968;18:20-33.
17. Boeve BF, Lang AE, Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol 2003;54 Suppl 5:S15-19.
18. Boeve BF, Maraganore DM, Parisi JE, et al. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology 1999;53:795-800.
19. Josephs KA, Dickson DW. Diagnostic accuracy of progressive supranuclear palsy in the Society for Progressive Supranuclear Palsy brain bank. Mov Disord 2003;18:1018-1026.
20. Osaki Y, Ben-Shlomo Y, Lees AJ, et al. Accuracy of clinical diagnosis of progressive supranuclear palsy. Mov Disord 2004;19:181-189.
21. Nobel W, Planel E, Zehr, et al. Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc Natl Acad Sci USA 2005;102:6990-6995.
22. Hodges JR, Davies RR, Xuereb JH, et al. Clinicopathological correlates in frontotemporal dementia. Ann Neurol 2004;56:399-406.
23. Rosen HJ, Hartikainen KM, Jagust W, et al. Utility of clinical criteria in differentiating frontotemporal lobar degeneration (FTLD) from AD. Neurology 2002;58:1608-1615.
24. Rascovsky K, Salmon DP, Ho GJ, et al. Cognitive profiles differ in autopsy-confirmed frontotemporal dementia and AD. Neurology 2002;58:1801-1808.
25. Knopman DF, Boeve BE, Parisi JE, et al. Antemortem diagnosis of frontotemporal lobar degeneration. Ann Neurol 2005;57:480-488.
26. Josephs KA, Knopman DS, Whitwell JL, et al. Survival in two variants of tau-negative frontotemporal lobar degeneration: FTLD-U vs FTLD-MND. Neurology 2005;65:645-647.
27. Lowe J. Establishing a pathological diagnosis in degenerative dementias. Brain Pathol 1998;8:403-406.
28. Dickson DW. Neurodegeneration: the molecular pathology of dementia and movement disorders. Basel: ISN Press, 2003.
29. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996;47:1-9.
30. Kertesz A, Munoz D. Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy. Dement Geriatr Cogn Disord 2004;17:282-286.
31. van Herpen E, Rosso SM, Serverijnen LA, et al. Variable phenotypic expression and extensive tau pathology in two families with the novel tau mutation L315R. Ann Neurol 2003;54:573-581.
32. Kobayashi K, Hayashi M, Kidani T, et al. Pick's disease pathology of a missense mutation of S305N of frontotemporal dementia and parkinsonism linked to chromosome 17: another phenotype of S305N. Dement Geriatr Cogn Disord 2004;17:293-297.
33. Ferrer I, Pastor P, Rey MJ, et al. Tau phosphorylation and kinase activation in familial tauopathy linked to deln296 mutation. Neuropathol Appl Neurobiol 2003;29:23-34.
34. Pickering-Brown S, Baker M, et al. Pick's disease is associated with mutations in the tau gene. Ann Neurol 2000;48:859-867.
35. Bugiani O, Murrell JR, Giaccone G, et al. Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. J Neuropathol Exp Neurol 1999;58:667-677.
36. Forbes RB, Colville S, Cran GW, Swingler RJ. Scottish Motor Neurone Disease Register. Unexpected decline in survival from amyotrophic lateral sclerosis/motor neurone disease. J Neurol Neurosurg Psychiatry 2004;75:1753-1755.
37. Kato S, Shaw P, Wood-Allum C, Leigh PN, Shaw C. Amyotrophic lateral sclerosis. In: Dickson DW, ed. Neurodegeneration: the molecular pathology of dementia and movement disorders. Basel: ISN Neuropath Press, 2003;251-256.
38. Josephs KA, Jones AG, Dickson DW. Hippocampal sclerosis and ubiquitin-positive inclusions in dementia lacking distinctive histopathology. Dement Geriatr Cogn Disord 2004;17:342-345.
39. Lipton AM, White CL 3rd, Bigio EH. Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration. Acta Neuropathol (Berl) 2004;108:379-385.
40. Broussolle E, Bakchine S, Tommasi M, et al. Slowly progressive anarthria with late anterior opercular syndrome: a variant form of frontal cortical atrophy syndromes. J Neurol Sci 1996;144:44-58.
41. Chapman SB, Rosenberg RN, Weiner MF, Shobe A. Autosomal dominant progressive syndrome of motor-speech loss without dementia. Neurology 1997;49:1298-1306.
42. Boeve B, Dickson D, Duffy J, Bartleson J, Trenerry M, Petersen R. Progressive nonfluent aphasia and subsequent aphasic dementia associated with atypical progressive supranuclear palsy pathology. Eur Neurol 2003;49:72-78.
43. Josephs KA, Boeve BF, Duffy J, et al. Atypical progressive supranuclear palsy underlying progressive apraxia of speech and nonfluent aphasia. Neurocase 2005;11:283-296.
44. Gorno-Tempini M, Murray R, Rankin K, Weiner M, Miller B. Clinical, cognitive and anatomical evolution from nonfluent progressive aphasia to corticobasal syndrome: a case report. Neurocase 2004;10:426-436.
45. Ferrer I, Hernandez I, Boada M, et al. Primary progressive aphasia as the initial manifestation of corticobasal degeneration and unusual tauopathies. Acta Neuropathol (Berl) 2003;106:419-435.
46. Oide T, Ohara S, Yazawa M, et al. Progressive supranuclear palsy with asymmetric tau pathology presenting with unilateral limb dystonia. Acta Neuropathol (Berl) 2002;104:209-214.
47. Barclay CL, Bergeron C, Lang AE. Arm levitation in progressive supranuclear palsy. Neurology 1999;52:879-882.